Search Articles

View query in Help articles search

Search Results (1 to 10 of 20 Results)

Download search results: CSV END BibTex RIS


Peer Review of “Financial Feasibility of Developing Sustained-Release Incrementally Modified Drugs in Thailand’s Pharmaceutical Industry: Mixed Methods Study”

Peer Review of “Financial Feasibility of Developing Sustained-Release Incrementally Modified Drugs in Thailand’s Pharmaceutical Industry: Mixed Methods Study”

Policy recommendations: Although the paper suggests policy recommendations, it would benefit from providing concrete examples of how these policies have been successfully implemented in other regions or industries. This would add depth and context to the recommendations. 4. References and citation quality: The paper relies on only 15 references, which is insufficient for a study of this scope.

Elena Shkarupeta

JMIRx Med 2025;6:e77627

Authors’ Response to Peer Reviews of “Financial Feasibility of Developing Sustained-Release Incrementally Modified Drugs in Thailand’s Pharmaceutical Industry: Mixed Methods Study”

Authors’ Response to Peer Reviews of “Financial Feasibility of Developing Sustained-Release Incrementally Modified Drugs in Thailand’s Pharmaceutical Industry: Mixed Methods Study”

Policy recommendations: Although the paper suggests policy recommendations, it would benefit from providing concrete examples of how these policies have been successfully implemented in other regions or industries. This would add depth and context to the recommendations. Response: Thank you for your valuable feedback on the policy recommendations section of our manuscript.

Manthana Laichapis, Rungpetch Sakulbumrungsil, Khunjira Udomaksorn, Nusaraporn Kessomboon, Osot Nerapusee, Charkkrit Hongthong, Sitanun Poonpolsub

JMIRx Med 2025;6:e77623

Financial Feasibility of Developing Sustained-Release Incrementally Modified Drugs in Thailand’s Pharmaceutical Industry: Mixed Methods Study

Financial Feasibility of Developing Sustained-Release Incrementally Modified Drugs in Thailand’s Pharmaceutical Industry: Mixed Methods Study

The Thai pharmaceutical industry is undergoing significant transformation in alignment with Thailand’s Pharmaceutical Development Action Plan (2023‐2027), which builds upon the foundation of earlier policies, including the National Strategic Master Plan (2018‐2037). These initiatives collectively emphasize enhancing the national drug system, fostering domestic pharmaceutical manufacturing capabilities, and achieving self-reliance through sustainable development [1-3].

Manthana Laichapis, Rungpetch Sakulbumrungsil, Khunjira Udomaksorn, Nusaraporn Kessomboon, Osot Nerapusee, Charkkrit Hongthong, Sitanun Poonpolsub

JMIRx Med 2025;6:e65978

Barriers to Implementing Registered Nurse–Driven Clinical Decision Support for Antibiotic Stewardship: Retrospective Case Study

Barriers to Implementing Registered Nurse–Driven Clinical Decision Support for Antibiotic Stewardship: Retrospective Case Study

Policies and laws, such as state regulatory laws and institutional policies, also had a strong impact on the study procedures and implementation. RN scope-of-practice varied by state and between institutions. Wisconsin has existing RN delegation protocols, allowing for more clinical autonomy among RNs than at institutions in New York and Utah.

Elizabeth R Stevens, Lynn Xu, JaeEun Kwon, Sumaiya Tasneem, Natalie Henning, Dawn Feldthouse, Eun Ji Kim, Rachel Hess, Katherine L Dauber-Decker, Paul D Smith, Wendy Halm, Pranisha Gautam-Goyal, David A Feldstein, Devin M Mann

JMIR Form Res 2024;8:e54996

The Conceptualization and Measurement of Research Impact in Primary Health Care: Protocol for a Rapid Scoping Review

The Conceptualization and Measurement of Research Impact in Primary Health Care: Protocol for a Rapid Scoping Review

High-income countries often possess robust health care systems with well-established PHC organizations and research institutions, making them pivotal in shaping global health policies and practices [3,4]. High-quality research identifying what is needed to strengthen the performance of PHC organizations and their integration with each other and the broader health system is essential to inform the sustainable development of health care [5].

Monica Aggarwal, Brian G Hutchison, Kristina M Kokorelias, Vivian R Ramsden, Noah M Ivers, Andrew Pinto, Ross E G Uphsur, Sabrina T Wong, Nick Pimlott, Steve Slade

JMIR Res Protoc 2024;13:e55860

Investigating the Roles and Responsibilities of Institutional Signing Officials After Data Sharing Policy Reform for Federally Funded Research in the United States: National Survey

Investigating the Roles and Responsibilities of Institutional Signing Officials After Data Sharing Policy Reform for Federally Funded Research in the United States: National Survey

The rapid growth in human research data, storage, and analysis tools and skilled researchers combined with the declining costs and new federal policies are creating an immense drive for research data sharing [1]. At the same, triangulating human research data of diverse types can accentuate the risks of reidentification when used for secondary research purposes.

Jinyoung Baek, Jonathan Lawson, Vasiliki Rahimzadeh

JMIR Form Res 2024;8:e49822